SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

14 Feb 2023 Evaluate
The Sales for the quarter ended December 2022 of Rs. 516.42 million declined by -41.03% from Rs. 875.71 millions.The Net Loss for the quarter ended December 2022 is Rs. -47.87 millions as compared to Net Profit of Rs. 67.21 millions of corresponding quarter ended December 2021The company reported a degrowth in operating Profit to 73.42 millions from 195.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 516.42 875.71 -41.03 1812.07 2843.18 -36.27 3569.52 2570.50 38.86
Other Income 175.97 120.14 46.47 483.12 302.87 59.51 408.62 322.46 26.72
PBIDT 73.42 195.32 -62.41 180.84 537.55 -66.36 625.49 656.16 -4.67
Interest 66.41 16.80 295.30 142.17 73.22 94.17 90.54 60.74 49.06
PBDT 7.01 178.52 -96.07 32.81 553.42 -94.07 623.04 1124.90 -44.61
Depreciation 122.57 90.53 35.39 345.69 245.27 40.94 348.18 222.81 56.27
PBT -115.56 87.99 -231.33 -312.88 308.15 -201.53 274.86 902.09 -69.53
TAX -67.69 20.78 -425.75 -107.30 51.82 -307.06 73.27 251.17 -70.83
Deferred Tax -47.50 5.41 -978.00 -34.25 20.04 -270.91 25.25 93.37 -72.96
PAT -47.87 67.21 -171.22 -205.58 256.33 -180.20 201.59 650.92 -69.03
Equity 86.80 86.80 0.00 86.80 86.80 0.00 86.80 81.53 6.46
PBIDTM(%) 14.22 22.30 -36.26 9.98 18.91 -47.22 17.52 25.53 -31.35

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×